DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C4284790 | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | RXYLT1 | 10329 | ribitol xylosyltransferase 1 | Q9Y2B1 |
C0025958 | Microcephaly | RXYLT1 | 10329 | ribitol xylosyltransferase 1 | Q9Y2B1 |
C0020255 | Hydrocephalus | RXYLT1 | 10329 | ribitol xylosyltransferase 1 | Q9Y2B1 |
C0007131 | Non-Small Cell Lung Carcinoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0027651 | Neoplasms | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0006826 | Malignant Neoplasms | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0007847 | Malignant tumor of cervix | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0700095 | Central neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0021400 | Influenza | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C1306459 | Primary malignant neoplasm | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C4048328 | cervical cancer | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0302592 | Cervix carcinoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0027819 | Neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0343641 | Human papilloma virus infection | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0002395 | Alzheimer's Disease | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0023470 | Myeloid Leukemia | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0007137 | Squamous cell carcinoma | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0027819 | Neuroblastoma | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0011847 | Diabetes | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0023434 | Chronic Lymphocytic Leukemia | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0524851 | Neurodegenerative Disorders | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0025149 | Medulloblastoma | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C1306459 | Primary malignant neoplasm | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0376358 | Malignant neoplasm of prostate | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
C0035335 | Retinoblastoma | SIGLEC7 | 27036 | sialic acid binding Ig like lectin 7 | Q9Y286 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024